Cover Image

Commentary: Neoadjuvant treatment of resectable pancreatic cancer: lack of level III evidence

Saved in:
Bibliographic Details
Main Authors: Schneider, Martin (Author) , Neoptolemos, John P. (Author) , Büchler, Markus W. (Author)
Format: Article (Journal) Editorial
Language:English
Published: 29 August 2020
In: Surgery
Year: 2020, Volume: 168, Issue: 6, Pages: 1015-1016
ISSN:1532-7361
DOI:10.1016/j.surg.2020.07.033
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.surg.2020.07.033
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0039606020305031
Get full text
Author Notes:Martin Schneider, MD, John P. Neoptolemos, MD, Markus W. Büchler, MD

MARC

LEADER 00000caa a2200000 c 4500
001 1744893284
003 DE-627
005 20220819080706.0
007 cr uuu---uuuuu
008 210118s2020 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.surg.2020.07.033  |2 doi 
035 |a (DE-627)1744893284 
035 |a (DE-599)KXP1744893284 
035 |a (OCoLC)1341388799 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schneider, Martin  |d 1976-  |e VerfasserIn  |0 (DE-588)12390384X  |0 (DE-627)706468147  |0 (DE-576)42325037X  |4 aut 
245 1 0 |a Commentary: Neoadjuvant treatment of resectable pancreatic cancer: lack of level III evidence  |c Martin Schneider, MD, John P. Neoptolemos, MD, Markus W. Büchler, MD 
264 1 |c 29 August 2020 
300 |a 2 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 18.01.2021 
700 1 |a Neoptolemos, John P.  |e VerfasserIn  |0 (DE-588)172283302  |0 (DE-627)697192954  |0 (DE-576)133150879  |4 aut 
700 1 |a Büchler, Markus W.  |d 1955-  |e VerfasserIn  |0 (DE-588)120893339  |0 (DE-627)080952526  |0 (DE-576)292434146  |4 aut 
773 0 8 |i Enthalten in  |t Surgery  |d Amsterdam [u.a.] : Elsevier, 1995  |g 168(2020), 6, Seite 1015-1016  |w (DE-627)315974907  |w (DE-600)2018278-8  |w (DE-576)093980949  |x 1532-7361  |7 nnas  |a Commentary: Neoadjuvant treatment of resectable pancreatic cancer: lack of level III evidence 
773 1 8 |g volume:168  |g year:2020  |g number:6  |g pages:1015-1016  |g extent:2  |a Commentary: Neoadjuvant treatment of resectable pancreatic cancer: lack of level III evidence 
856 4 0 |u https://doi.org/10.1016/j.surg.2020.07.033  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0039606020305031  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210118 
993 |a Editorial 
994 |a 2020 
998 |g 120893339  |a Büchler, Markus W.  |m 120893339:Büchler, Markus W.  |d 910000  |d 910200  |e 910000PB120893339  |e 910200PB120893339  |k 0/910000/  |k 1/910000/910200/  |p 3  |y j 
998 |g 172283302  |a Neoptolemos, John P.  |m 172283302:Neoptolemos, John P.  |d 910000  |d 910200  |e 910000PN172283302  |e 910200PN172283302  |k 0/910000/  |k 1/910000/910200/  |p 2 
998 |g 12390384X  |a Schneider, Martin  |m 12390384X:Schneider, Martin  |d 910000  |d 910200  |e 910000PS12390384X  |e 910200PS12390384X  |k 0/910000/  |k 1/910000/910200/  |p 1  |x j 
999 |a KXP-PPN1744893284  |e 3838855884 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 18.01.2021"],"relHost":[{"origin":[{"publisher":"Elsevier ; Mosby","dateIssuedKey":"1995","dateIssuedDisp":"1995-","publisherPlace":"Amsterdam [u.a.] ; St. Louis, Mo."}],"id":{"eki":["315974907"],"zdb":["2018278-8"],"issn":["1532-7361"]},"part":{"pages":"1015-1016","volume":"168","extent":"2","text":"168(2020), 6, Seite 1015-1016","year":"2020","issue":"6"},"recId":"315974907","name":{"displayForm":["Society of University Surgeons"]},"disp":"Commentary: Neoadjuvant treatment of resectable pancreatic cancer: lack of level III evidenceSurgery","title":[{"title_sort":"Surgery","title":"Surgery","subtitle":"a monthly journal devoted to the art and science of surgery"}],"note":["Gesehen am 19.07.2023"],"corporate":[{"role":"isb","display":"Society of University Surgeons"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"pubHistory":["Nachgewiesen 117.1995 -"]}],"title":[{"title_sort":"Commentary: Neoadjuvant treatment of resectable pancreatic cancer: lack of level III evidence","title":"Commentary: Neoadjuvant treatment of resectable pancreatic cancer: lack of level III evidence"}],"person":[{"display":"Schneider, Martin","family":"Schneider","given":"Martin","role":"aut"},{"display":"Neoptolemos, John P.","role":"aut","given":"John P.","family":"Neoptolemos"},{"family":"Büchler","role":"aut","given":"Markus W.","display":"Büchler, Markus W."}],"physDesc":[{"extent":"2 S."}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"29 August 2020","dateIssuedKey":"2020"}],"id":{"doi":["10.1016/j.surg.2020.07.033"],"eki":["1744893284"]},"recId":"1744893284","name":{"displayForm":["Martin Schneider, MD, John P. Neoptolemos, MD, Markus W. Büchler, MD"]}} 
SRT |a SCHNEIDERMCOMMENTARY2920 

Similar Items